Europe, the Middle East and Africa. Sponsored Research and Collaborations. Last $ 189.62. 080715 4:00 PM ET. Alexion Pharmaceuticals to Report Second Quarter 2015 Results on Thursday, July 30, 2015. Thu, 30 Jul, 2015 - 10:00 AM ET Listen to Webcast ». 2Q 2015 Earnings Slides. Please see Full Prescribing Information. And Important Safety Information.
http://ir.alexionpharm.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
PAGES IN
THIS WEBSITE
18
SSL
EXTERNAL LINKS
46
SITE IP
206.200.251.19
LOAD TIME
0 sec
SCORE
6.2
Alexion Pharmaceuticals, Inc. - Investor Relations | ir.alexionpharm.com Reviews
https://ir.alexionpharm.com
Europe, the Middle East and Africa. Sponsored Research and Collaborations. Last $ 189.62. 080715 4:00 PM ET. Alexion Pharmaceuticals to Report Second Quarter 2015 Results on Thursday, July 30, 2015. Thu, 30 Jul, 2015 - 10:00 AM ET Listen to Webcast ». 2Q 2015 Earnings Slides. Please see Full Prescribing Information. And Important Safety Information.
ir.alexionpharm.com
Alexion Pharmaceuticals, Inc. - Stock Information
http://ir.alexionpharm.com/stockquote.cfm
Europe, the Middle East and Africa. Eculizumab in Other Diseases. Sponsored Research and Collaborations. Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN). 4:00 PM ET on Friday, Aug 26, 2016. Sign up for email alerts. Transfer Agent: Computershare, N.A. Please see Full Prescribing Information. And Important Safety Information. This website is intended only for residents of the United States. Sponsored Research and Collaborations. This website is intended only for. Residents of the United States.
Alexion Pharmaceuticals, Inc. - Annual Reports to Shareholders
http://ir.alexionpharm.com/annuals.cfm
Europe, the Middle East and Africa. Eculizumab in Other Diseases. Sponsored Research and Collaborations. Annual Reports to Shareholders. Alexion Pharmaceuticals 2015 Annual Report. Alexion Pharmaceuticals 2014 Annual Report. Breakthrough Medical Innovation for Severe and Life-Threatening Disorders. Alexion Pharmaceuticals 2013 Annual Report. Breakthrough Medical Innovation for Patients with Severe and Rare Disorders. Alexion Pharmaceuticals 2012 Annual Report. Alexion Pharmaceuticals 2011 Annual Report.
Alexion Pharmaceuticals, Inc. - SEC Filings
http://ir.alexionpharm.com/sec.cfm
Europe, the Middle East and Africa. Eculizumab in Other Diseases. Sponsored Research and Collaborations. Parven, alvin s. Wednesday, Aug 24, 2016. Wagner, heidi l. Wednesday, Aug 10, 2016. Wednesday, Aug 10, 2016. Moriarty, john b. Wednesday, Aug 10, 2016. Wednesday, Aug 10, 2016. Wednesday, Aug 10, 2016. Wednesday, Aug 10, 2016. Amended Statement of Beneficial Ownership. Wednesday, Aug 10, 2016. Monday, Aug 8, 2016. Friday, Jul 29, 2016. Thursday, Jul 28, 2016. Moriarty, john b. Tuesday, Jun 14, 2016.
Alexion Pharmaceuticals, Inc. - Board of Directors
http://ir.alexionpharm.com/directors.cfm
Europe, the Middle East and Africa. Eculizumab in Other Diseases. Sponsored Research and Collaborations. Leonard Bell, M.D. Felix J. Baker Ph.D. Felix J. Baker, Ph.D. has been a director of Alexion since June 2015. Dr. Baker is a Managing Partner of Baker Brothers Investments which he and his brother, Julian Baker, founded in 2000. Dr. Baker’s career as a fund-manager began in 1994 when he co-founded a biotechnology investing partnership with the Tisch Family. Dr Baker holds a B.S. and a Ph.D...Member of...
Alexion Pharmaceuticals, Inc. - Acquisitions
http://ir.alexionpharm.com/acquisitions.cfm
Europe, the Middle East and Africa. Eculizumab in Other Diseases. Sponsored Research and Collaborations. Effective January 28, 2011, Alexion completed its acquisition of Taligen Therapeutics. The shareholders of Taligen Therapeutics have appointed Shareholder Representative Services as the shareholders' respresentative. If you have questions relating to your rights as a former Taligen shareholder, please contact taligen@shareholderrep.com. Please see Full Prescribing Information.
TOTAL PAGES IN THIS WEBSITE
18
Strensiq® (asfotase alfa) Receives Marketing Approval in Japan for Treatment of Patients with Hypophosphatasia (HPP) | Alexion Pharmaceuticals, Inc
http://news.alexionpharma.com/press-release/company-news/strensiq-asfotase-alfa-receives-marketing-approval-japan-treatment-patien
Europe, the Middle East and Africa. Eculizumab in Other Diseases. LAL Deficiency and Sebelipase Alfa. Sponsored Research and Collaborations. Strensiq (asfotase alfa) Receives Marketing Approval in Japan for Tr. Strensiq (asfotase alfa) Receives Marketing Approval in Japan for Treatment of Patients with Hypophosphatasia (HPP). First Approved Treatment for Japanese Patients Suffering from HPP, a Life-Threatening Ultra-Rare Metabolic Disorder. Monday, July 6, 2015 6:00 am EDT. HPP is a genetic, progressive,...
company-news | Alexion Pharmaceuticals, Inc
http://news.alexionpharma.com/news/all/all/company-news
Europe, the Middle East and Africa. Eculizumab in Other Diseases. LAL Deficiency and Sebelipase Alfa. Sponsored Research and Collaborations. Your search yielded no results. Please see Full Prescribing Information. And Important Safety Information. This website is intended only for residents of the United States. Sponsored Research and Collaborations. This website is intended only for. Residents of the United States.
Alexion Pharmaceuticals in the United States | Location Information
http://alexion.com/SelectCountry/USA.aspx
Europe, the Middle East and Africa. Corporate Giving and Support. Eculizumab in Other Diseases. Sponsored Research and Collaborations. United States of America. Global and Regional Headquarters:. 1 (203) 272 2596. 1 (203) 271 8189. 1455 Pennsylvania Avenue, NW #510. 1 (202) 688 6650. 1 (202) 688 6657. 1 (617) 674 5720. 1 (617) 374 4792. Lexington, MA 02421. 1 (781) 357 9900. 1 (781) 357 9901. Alexion Rhode Island Manufacturing Facility:. 1 (401) 233 1200. 1 (401) 233 1210. And Important Safety Information.
Alexion Pharmaceuticals in Norway | Location Information
http://alexion.com/SelectCountry/Norway.aspx
Europe, the Middle East and Africa. Corporate Giving and Support. Eculizumab in Other Diseases. Sponsored Research and Collaborations. Alexion Pharma Nordics AB has operations in Norway to serve patients locally. Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with severe and life-threatening rare disorders. Alexion Pharma Nordics AB. 46 (0) 8 557 727 50. Please see Full Prescribing Information. And Important Safety Information.
Alexion Pharmaceuticals, Inc (NASDAQ: ALXN) | World Leader in Treatments for Patients with Devastating and Rare Diseases
http://alexion.com/default.aspx
Europe, the Middle East and Africa. Corporate Giving and Support. Eculizumab in Other Diseases. Sponsored Research and Collaborations. We see the unseen. At Alexion, we see opportunities where others do not and we have the courage to explore what others believe is impossible. We see patients suffering from devastating diseases that are often overlooked. We see a pathway from innovative science to the delivery of breakthrough therapies. We see an opportunity to transform lives. By redefining innovation, w...
Alexion Pharmaceuticals in Belgium | Location Information
http://alexion.com/SelectCountry/Belgium.aspx
Europe, the Middle East and Africa. Corporate Giving and Support. Eculizumab in Other Diseases. Sponsored Research and Collaborations. Alexion has operations in Belgium to serve patients locally. Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with severe and life-threatening rare disorders. Alexion Pharma Belgium SPRL. Rue de la Régence 58. 32 (0)2 548 36 36. 32 (0)2 548 36 45. Please see Full Prescribing Information.
Alexion Pharmaceuticals in the Netherlands | Location Information
http://alexion.com/SelectCountry/Netherlands.aspx
Europe, the Middle East and Africa. Corporate Giving and Support. Eculizumab in Other Diseases. Sponsored Research and Collaborations. Alexion has operations in Netherlands to serve patients locally. Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with severe and life-threatening rare disorders. Alexion Pharma Netherlands B.V. 31 (0) 20 521 94 55. 31 (0) 20 521 93 33. Please see Full Prescribing Information.
Alexion Pharmaceuticals in France | Location Information
http://alexion.com/SelectCountry/France.aspx
Europe, the Middle East and Africa. Corporate Giving and Support. Eculizumab in Other Diseases. Sponsored Research and Collaborations. Alexion has operations in France to serve patients locally. Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies patients with severe and life-threatening rare disorders. Alexion Pharma France SAS. 1-15, avenue Edouard Belin. 33 (1) 47 32 36 21. 33 (1) 47 10 24 46. Please see Full Prescribing Information.
Alexion Pharmaceuticals in Ireland | Location Information
http://alexion.com/SelectCountry/Ireland.aspx
Europe, the Middle East and Africa. Corporate Giving and Support. Eculizumab in Other Diseases. Sponsored Research and Collaborations. Alexion has global supply chain and distribution operations in Ireland. For further information about Alexion’s operations in Ireland please contact: alexion.ireland@alxn.com. Learn more about Alexion in Ireland. Alexion Pharma International Trading. College Business and Technology Park. 353 (0) 1 254 6400. 353 (0)1 633 5629. 44 (0) 208 744 6600.
TOTAL LINKS TO THIS WEBSITE
46
Investors - Akebia Therapeutics
ELEVATION 5,250 ft. HIF regulation could have therapeutic uses across a variety of conditions. We are a biopharmaceutical company focused on the development of novel proprietary therapeutics based on hypoxia inducible factor, or HIF, biology and the commercialization of these products for patients with kidney disease. Aug 11, 2015. Akebia Announces Second Quarter 2015 Financial Results. Jun 16, 2015. Akebia to Present at the 2015 JMP Securities Life Sciences Conference. View all press releases ».
Investor Relations | Akers Biosciences, Inc.
The Company is incorporated in the United States in the State of New Jersey where all corporate operations currently reside. The rights of shareholders may be different from the rights of shareholders in a UK incorporated company. There are no restrictions on the trading of ABI's shares on AIM . Day High: 3.86. Day Low: 3.77. Aug 14, 2015. Delayed 20 min., by eSignal. Day High: 245.25. Day Low: 245.00. Aug 14, 2015. Delayed 20 min., by eSignal. Aug 14, 2015. Aug 13, 2015. View all press releases ».
Investor Relations - Investor Relations
Your partner in aquaculture technology. AKVA group is the global leader in delivering technology to the aquaculture industry. The shares of AKVA group are traded on the Oslo Stock Exchange from November 2006. The company will strive to provide the market with relevant information according to the current regulations. It will always be an objective to give correct, relevant and timely information to all market participants at the same time. AKVA group ASA : 1Q 2015 financial reporting. Tel 47 916 39 831.
Investor Relations - Investor Relations - Albany International Corp.
Q2 2015 Albany International Corp Earnings Conference Call. 160;at 9:00 am ET. Q2 2015 Albany International Corp Earnings Conference Call. Wednesday, August 5, 2015 . 9:00 am ET . Click here for webcast. Click here to add this event to your calendar. Q3 2014 Albany International Corp Earnings Conference Call. Tuesday, November 4, 2014 9:00 am ET. Q3 2014 Financial Results. Q3 2014 Earnings Call Presentation. Albany International Reports Second-Quarter Results. Tuesday, August 4, 2015 - 5:00 pm. Replicat...
Investors - Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics is a clinical-stage biotechnology company focused primarily on the development of products to treat diseases thought to be related to endogenous free aldehydes, a naturally occurring class of toxic molecules. The company has developed NS2, a product candidate designed to trap free aldehydes. Aldeyra has initiated clinical testing of NS2 for the treatment of Sjögren-Larsson Syndrome and noninfectious anterior uveitis. Aldeyra Therapeutics Corporate Presentation - August 2015. Aldeyra ...
Alexion Pharmaceuticals, Inc. - Investor Relations
Europe, the Middle East and Africa. Sponsored Research and Collaborations. Last $ 189.62. 080715 4:00 PM ET. Alexion Pharmaceuticals to Report Second Quarter 2015 Results on Thursday, July 30, 2015. Thu, 30 Jul, 2015 - 10:00 AM ET Listen to Webcast ». 2Q 2015 Earnings Slides. Please see Full Prescribing Information. And Important Safety Information.
Algodon Wines & Luxury Development Group, Inc.
Algodon Wine and Luxury Development Group. How to Invest with Us. Algodon Uncorks Preview of 2015 Wine Line and New Blend for Chinese Market. Dec 16, 2014. Located in the city's most elegant residential neighborhood of Recoleta, as well as the Mendoza wine resort called Algodon Wine Estates. Sign up for email alerts. Be the first to receive breaking news. All Securities offered through DPEC Capital, Inc. (Member FINRA.
Investors | ALK
House dust mite allergy. What is allergic asthma. How is allergy diagnosed. Treating allergy and asthma. Annual general meeting (DK). ALK at a glance. Grant of share options and performance shares to members of the Board of Management and key employees. Annual General Meeting in ALK-Abelló A/S held on 12 March 2018. New medicine for house dust mite allergic rhinitis and allergic asthma now available in France. ALK's partner, Torii, gains paediatric approval for the house dust mite SLIT-tablet in Japan.
IR Portal // All for One Steeb
All for One Steeb. Social Media News Room. Nachhaltig und profitabel wachsen. Equity Story nachhaltiges Wertsteigerungspotenzial. Die All for One Steeb AG ist die Nummer 1. Im SAP-Markt in der deutschsprachigen Region und führendes IT-Haus:. Größte SAP Mittelstandskunden Basis mit Softwarewartungs- und Outsourcing/Cloud Services Verträgen. Hoher Anteil wiederkehrender Erlöse Treiber für Skaleneffekte, Profitabilität und Cash-Flow. Einzigartiges Geschäftsmodell stark fokussiert. Die All for One Steeb AG, ...
پورتال بیزنس ايران > بصورت جدید در https://ir.all.biz تجارت کن
مرکز جهانی تجارت اینترنتی. 1,4 million of companies and 16 million of custiomers around the world. Create a lead for. And sellers will contact you. Suppliers will contact you. لوازم خودرو و موتور. بصورت جدید در https:/ ir.all.biz تجارت کن". تجهیزات تامین آب، گاز و حرارت. بصورت جدید در https:/ ir.all.biz تجارت کن". چوب بست، تخته و الوار. بصورت جدید در https:/ ir.all.biz تجارت کن". وسایل خانه داری و باغداری. بصورت جدید در https:/ ir.all.biz تجارت کن". لوازم بهداشتی و آرایشی. محصولات غذایی و آشامیدنی. بصورت...
Investor Overview | Investor Relations | Allegiant Air
Skip to main content. We appreciate your interest in Allegiant. This site is designed to provide you up-to-date information on Allegiant Travel Company (ALGT), the parent company of Allegiant Air and Allegiant Vacations. 160; 3.96. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay. Allegiant Reports July 2015 Traffic. Allegiant Travel Company Second Quarter 2015 Financial Results. Untitled Document Click to Tweet: .@AllegiantTravel announces further expansion from @flymemphis with new flights t...
SOCIAL ENGAGEMENT